Mitocin 20 mg

GIF decision: Withdrawal from market

What does this decision mean?

  • Wycofanie z obrotu — Some of the products covered by the decision were withdrawn from the market — please return them to the pharmacy/distributor.

In batch no. 0-20022AB an out-of-specification result was found due to the presence of visible particles in the product intended for solution for injection. Potential effects: embolism, inflammation, inflammatory reactions, local or systemic complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Mitocin 20 mg
Risk Level
Critical
Manufacturer
podmiot odpowiedzialny: Vygoris Limited podmiot, który uzyskał zgodę na czasowe dopuszczenie do obrotu produktu leczniczego: Profarm Sp. z o.o. ul. Słoneczna 96, 05-500 Stara Iwiczna
Batch Number
0-20022AB
Notice Date
17.09.2021
View official statement
Source: GIF view the official alert

What to do if you have this product?

A recall means the product may be unsafe. Here is what to do if you have it at home.

  1. 1

    Do not eat or use the product

    Stop using or consuming it immediately and keep it out of reach of children.

  2. 2

    Check the batch number and expiry date

    Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.

  3. 3

    Return it to the shop

    You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.

  4. 4

    Get help and report it

    If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.

General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.

Important Information

What You Should Know

Recommendations

Do not use the product from batch 0-20022AB. Entities holding this batch should immediately stop its use and return it to the wholesaler. Patients who received the product from this batch and experien...

Actions Taken

The Chief Pharmaceutical Inspector withdrew batch 0-20022AB of Mitocin 20 mg from the market throughout the country and granted the decision immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

Related

Other Notices